Sanofi India block deals, bulk deals, insider trading and stake changes
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,189.50up ₹197.50 (6.60%)BSE ₹3,189.65
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,992.00.
29 Oct: open ₹3,010.00, high ₹3,209.00, low ₹3,010.00
52-week range of traded prices to 29 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,898.00High, 29 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,346 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.86%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 96,23823.1% delivered
Sanofi India's insiders have 2 trade disclosures on record, the latest on 28 Sep 2026. Its promoter group made no purchase or sale on the market in the 12 months to 29 Oct 2026.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Sanofi India promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 2 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Sanofi India insider trading
Sep 2026
- Sanofi Healthcare India Private Limited₹1,068 Cr35,00,000 sharesReceived · Promoter Group · 24 Sep 2026 · disclosed 25 Sep · Inter-se-Transfer · held none before, holds 35,00,000 after, stake 15.20% after
- Hoechst GmbH₹1,068 Cr35,00,000 sharesGave · Promoter · 24 Sep 2026 · disclosed 25 Sep · Inter-se-Transfer · stake 60.38% before, 45.18% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Sanofi India stake sales and purchases
All 11 disclosures on record.
Sep 2026
- SoldHoechst GmbH · promoter15.20% of the company35,00,000 sharesholds 45.18% after24 Sep 2026 · filed under the 2% rule · Inter-se transfer
Nov 2021
- AcquiredLife Insurance Corporation of India2.04% of the company4,70,529 sharesholds 5.12% after9 Nov 2021 · filed under the 2% rule
Oct 2021
- AcquiredLife Insurance Corporation of India0.02% of the company5,094 sharesholds 5.00% after27 Oct 2021 · filed under the 5% rule
Mar 2020
- SoldAberdeen Standard Investments ( Asia)ltd0.03% of the company7,320 sharesholds 4.25% after5 Mar 2020 · filed under the 2% rule · Open Market
Apr 2018
- SoldAberdeen Asset Management Asia Ltd.. on behalf of funds advised / managed1,967 sharesholds 6.28% after3 Apr 2018 · filed under the 2% rule · Open Market
Aug 2017
- AcquiredAberdeen Asset Management Asia Ltdholds 8.28% after14 Aug 2017 · filed under the 2% rule
- SoldAberdeen Asset Management Asia Ltd.229 sharesholds 8.28% after14 Aug 2017 · filed under the 2% rule · Open Market
Jan 2017
1 entry
- SoldAberdeen Asset Management Asia Ltd0.22% of the company51,743 sharesholds 8.05% after5 Jan 2017 · filed under the 2% rule · Open Market
Jun 2016
1 entry
- SoldReliance Nippon Life Asset Management Limited0.11% of the company25,000 sharesholds 3.34% after27 Jun 2016 · filed under the 2% rule · Open Market
Sep 2015
2 entries
- SoldAberdeen Asset Management Asia Ltd0.03% of the company7,534 sharesholds 10.13% after23 Sep 2015 · filed under the 2% rule · Open Market
- SoldAberdeen Asset Management Asia Ltd on behalf of funds advised/ managed0.03% of the company7,534 sharesholds 10.13% after23 Sep 2015 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Sanofi India block deals and bulk deals
Last 12 months, since 30 Oct 2025: 1 block deal and 3 bulk deals, ₹2,220 Cr bought and ₹2,223 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 24 Sep 20264 firms · ₹2,136 Cr bought · ₹2,136 Cr soldNet nil
- SoldHOECHST GMBHBlock dealSold 35,00,000 at ₹3,052.0015.20% of the company₹1,068 Cr
- SoldHOECHST GMBHSold 35,00,000 at ₹3,052.0015.20% of the company₹1,068 Cr
- BoughtSANOFI HEALTHCARE INDIA PRIVATE LIMITEDBlock dealBought 35,00,000 at ₹3,052.0015.20% of the company₹1,068 Cr
- BoughtSANOFI HEALTHCARE INDIA PRIVATE LIMITEDBought 35,00,000 at ₹3,052.0015.20% of the company₹1,068 Cr
Friday 12 Jun 20262 firms · ₹83 Cr bought · ₹87 Cr soldNet sold ₹3.43 Cr
- SoldHDFC LIFE INSURANCE COMPANY LIMITEDSold 2,75,000 at ₹3,150.001.19% of the company₹87 Cr
- BoughtNIPPON INDIA MUTUAL FUNDBought 2,64,118 at ₹3,150.001.15% of the company₹83 Cr
Monday 17 Oct 20224 firms · ₹25 Cr bought · ₹25 Cr soldNet nil
- SoldISHARES CORE EMERGING MARKETS MAURITIUS COBlock dealSold 38,863 at ₹5,743.700.17% of the company₹22 Cr
- BoughtISHARES CORE MSCI EMERGING MARKETS ETFBlock dealBought 38,863 at ₹5,743.700.17% of the company₹22 Cr
- SoldISHARES INDIA SC MAURITIUS COMPANYBlock dealSold 4,485 at ₹5,743.700.02% of the company₹2.58 Cr
- BoughtISHARES MSCI INDIA SMALL-CAP ETFBlock dealBought 4,485 at ₹5,743.700.02% of the company₹2.58 Cr
Tuesday 11 Oct 20224 firms · ₹12 Cr bought · ₹12 Cr soldNet nil
- SoldISHARES CORE EMERGING MARKETS MAURITIUS COBlock dealSold 18,905 at ₹5,887.200.08% of the company₹11 Cr
- BoughtISHARES CORE MSCI EMERGING MARKETS ETFBlock dealBought 18,905 at ₹5,887.200.08% of the company₹11 Cr
- SoldISHARES INDIA SC MAURITIUS COMPANYBlock dealSold 2,180 at ₹5,887.200.01% of the company₹1.28 Cr
- BoughtISHARES MSCI INDIA SMALL-CAP ETFBlock dealBought 2,180 at ₹5,887.200.01% of the company₹1.28 Cr
Monday 3 Oct 20224 firms · ₹12 Cr bought · ₹12 Cr soldNet nil
- SoldISHARES CORE EMERGING MARKETS MAURITIUS COBlock dealSold 18,878 at ₹5,780.800.08% of the company₹11 Cr
- BoughtISHARES CORE MSCI EMERGING MARKETS ETFBlock dealBought 18,878 at ₹5,780.800.08% of the company₹11 Cr
- SoldISHARES INDIA SC MAURITIUS COMPANYBlock dealSold 2,177 at ₹5,780.800.01% of the company₹1.26 Cr
- BoughtISHARES MSCI INDIA SMALL-CAP ETFBlock dealBought 2,177 at ₹5,780.800.01% of the company₹1.26 Cr
Monday 19 Sep 20224 firms · ₹11 Cr bought · ₹11 Cr soldNet nil
- SoldISHARES CORE EMERGING MARKETS MAURITIUS COBlock dealSold 16,199 at ₹6,056.950.07% of the company₹9.81 Cr
- BoughtISHARES CORE MSCI EMERGING MARKETS ETFBlock dealBought 16,199 at ₹6,056.950.07% of the company₹9.81 Cr
- SoldISHARES INDIA SC MAURITIUS COMPANYBlock dealSold 1,869 at ₹6,056.950.01% of the company₹1.13 Cr
- BoughtISHARES MSCI INDIA SMALL-CAP ETFBlock dealBought 1,869 at ₹6,056.950.01% of the company₹1.13 Cr
Tuesday 8 Mar 20162 firms · ₹37 Cr bought · ₹37 Cr soldNet nil
- SoldNEW INDIA INVESTMENT COMPANY MAURITIUS LIMITEDBlock dealSold 85,000 at ₹4,400.750.37% of the company₹37 Cr
- BoughtNEW INDIA INVESTMENT TRUST PLCBlock dealBought 85,000 at ₹4,400.750.37% of the company₹37 Cr
Wednesday 19 Dec 20072 firms · ₹15 Cr bought · ₹25 Cr soldNet sold ₹9.90 Cr
- SoldMORGAN ST GROWTH FUNDSold 2,49,000 at ₹1,000.001.08% of the company₹25 Cr
- BoughtRELIANCE CAPITAL TRUSTEE CO.LTD.Bought 1,50,000 at ₹1,000.000.65% of the company₹15 Cr
Tuesday 13 Nov 20071 firm · ₹0 bought · ₹15 Cr soldNet sold ₹15 Cr
- SoldCITIGROUP GLOBAL MARKET M PVT LTDSold 1,50,000 at ₹988.00₹15 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 16 deals on record from 4 Jan 2004.